{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-026669","form_type":"8-K","ticker":"BDSX","cik":"0001439725","company_name":"BIODESIX INC","filed_at":"2022-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.670288+00:00","generated_at":"2026-06-21T03:15:45.622134+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Biodesix appoints Lawrence T. Kennedy to Board of Directors, effective Jan 3, 2023","bullets":["Kennedy appointed to Board and Audit Committee, effective Jan 3, 2023.","He brings 20+ years healthcare operating, finance, and investment experience; managing partner/CEO of Westwood Management.","Initial equity grant of $375K (50% NQSOs, 50% RSUs) plus prorated annual grant of $46,411 in RSUs.","Senior Mgmt Bonus to Equity Plan amended: Multiplier reduced from 4 to 3, and Company may limit election by percentage."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-026669","json":"https://secwatch.observer/filing/0000950170-22-026669.json","markdown":"https://secwatch.observer/filing/0000950170-22-026669.md","text":"https://secwatch.observer/filing/0000950170-22-026669.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022026669/0000950170-22-026669-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022026669/bdsx-20221214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T03:15:45.622134+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f285bc1811","claim":"Lawrence (Lair) T. Kennedy was appointed as Director at BIODESIX INC.","evidence_excerpt":"On December 15, 2022, Lawrence (Lair) T. Kennedy was elected and appointed to the Board of Directors of Biodesix, Inc. (the “Company”), with such appointment to be effective and service to commence on January 3, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022026669/0000950170-22-026669-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}